Search bioRxiv⌕ Search

Biology subjects

Vazquez, M. J.

Publications and source records attributed to Vazquez, M. J..

2 recordsLinked to original sources

Dissecting the KNDy hypothesis: KNDy neuron-derived kisspeptins are dispensable for puberty but essential for preserved female fertility and gonadotropin pulsatility

Kiss1 neurons in the hypothalamic arcuate-nucleus (ARC) play key roles in the control of GnRH pulsatility and fertility. A fraction of ARC Kiss1 neurons, termed KNDy, co-express neurokinin B (NKB; encoded by Tac2). Yet, NKB- and Kiss1-only neurons are also found in the ARC, while a second major Kiss1-neuronal population is present in the rostral hypothalamus. The specific contribution of different Kiss1 neuron sub-sets to reproductive control remains unfolded. To tease apart the physiological roles of KNDy-born kisspeptins, conditional ablation of Kiss1 in Tac2-expressing cells was implemented in vivo. Mice with Tac2 cell-specific Kiss1 KO (TaKKO) displayed reduced ARC kisspeptin content and Kiss1 expression, with greater suppression in females, which was detectable at infantile-pubertal age. In contrast, Tac2/NKB levels were fully preserved. Despite the drop of ARC Kiss1/kisspeptin, pubertal timing was normal in TaKKO mice of both sexes. However, young-adult TaKKO females displayed disturbed LH pulsatility and sex steroid levels, with suppressed basal LH and pre-ovulatory LH surges, early-onset subfertility and premature ovarian insufficiency. Conversely, testicular histology and fertility were grossly conserved in TaKKO males. Ablation of Kiss1 in Tac2-cells led also to sex-dependent alterations in body composition, glucose homeostasis and locomotor activity. Our data document that KNDy-born kisspeptins are dispensable/compensable for puberty in both sexes, but required for maintenance of female gonadotropin pulsatility and fertility, as well as adult metabolic homeostasis. Significance StatementNeurons in the hypothalamic arcuate nucleus (ARC) co-expressing kisspeptins and NKB, named KNDy, have been recently suggested to play a key role in pulsatile secretion of gonadotropins, and hence reproduction. However, the relative contribution of this Kiss1 neuronal-subset, vs. ARC Kiss1-only and NKB-only neurons, as well as other Kiss1 neuronal populations, has not been assessed in physiological settings. We report here findings in a novel mouse-model with elimination of KNDy-born kisspeptins, without altering other kisspeptin compartments. Our data highlights the heterogeneity of ARC Kiss1 populations and document that, while dispensable/compensable for puberty, KNDy-born kisspeptins are required for proper gonadotropin pulsatility and fertility, specifically in females. Characterization of this functional diversity is especially relevant, considering the potential of kisspeptin-based therapies for management of human reproductive disorders. Disclosure StatementThe authors have nothing to disclose in relation to the contents of this work.

physiology↗

Tetrahydrocannabinolic Acid A (THCA-A) Reduces Adiposity And Prevents Metabolic Disease Caused By Diet-Induced Obesity

Cannabis has remarkable therapeutic potential, but its clinical use is limited by the psychotropic activity of {Delta}9-tetrahydrocannabinol ({Delta}9-THC). Surprisingly, the biological profile of the non-narcotic native precursor of {Delta}9-THC ({Delta}9-THC acid A, {Delta}9-THCA-A) is still largely unexplored. We present evidence that {Delta}9-THCA-A is a partial and selective PPAR{gamma} modulator, endowed with lower adipogenic activity than the full PPAR{gamma} agonist rosiglitazone (RGZ) and with an enhanced osteoblastogenic activity in human mesenchymal stem cells. Docking and in vitro functional assays indicated that {Delta}9-THCA-A binds to and activates PPAR{gamma} by acting at both the canonical and the alternative sites of the ligand-binding domain. Transcriptomic signatures at inguinal white adipose tissue (iWAT) from mice treated with {Delta}9-THCA-A confirmed its mode of action on PPAR{gamma}. Administration of {Delta}9-THCA-A in a mouse model of high fat diet (HFD)-induced obesity significantly reduced fat mass and body weight gain, markedly ameliorating glucose intolerance and insulin resistance, and largely preventing liver steatosis, adipogenesis and macrophage infiltration in fat tissues. Additionally, immunohistochemistry, transcriptomic, and plasma biomarker analyses showed that treatment with {Delta}9-THCA-A caused browning of iWAT and displayed potent anti-inflammatory actions in HFD mice. Altogether, our data validate the potential of {Delta}9-THCA-A as a low adipogenic PPAR{gamma} agonist, capable of substantially improving the symptoms of obesity-associated metabolic syndrome and inflammation. These findings suggest that {Delta}9-THCA-A, and perhaps non-decarboxylated Cannabis sativa extracts, are worth considering for addition to our inventory of cannabis medicines.\n\nSIGNIFICANCE STATEMENTThe medicinal use of Cannabis is gaining momentum, despite the adverse psychotropic effects of {Delta}9-THC, the decarboxylation product of its naturally occurring and non-psychotropic precursor {Delta}9-THCA-A. We present evidence that {Delta}9-THCA-A is a partial ligand agonist of PPAR{gamma} with lower adipogenic activity compared to the full PPAR{gamma} agonist rosiglitazone (RGZ). Moreover, chronic administration of {Delta}9-THCA-A in a mouse model of high fat diet (HFD)-induced obesity significantly reduced body weight gain and fat mass, improved glucose intolerance and insulin resistance, and prevented liver steatosis and macrophage infiltration in fat tissues, additionally inducing white adipose tissue browning. Collectively, these observations qualify {Delta}9-THCA-A, a compound devoid of psychotropic effects, as an efficacious pharmacological agent to manage metabolic syndrome and obesity-associated inflammation.\n\nHighlights- {Delta}9-THCA-A is a partial PPAR{gamma} ligand agonist with low adipogenic activity\n- {Delta}9-THCA-A enhances osteoblastogenesis in bone marrow derived mesenchymal stem cells.\n- {Delta}9-THCA-A reduces body weight gain, fat mass, and liver steatosis in HFD-fed mice\n- {Delta}9-THCA-A improves glucose tolerance, insulin sensitivity, and insulin profiles in vivo\n- {Delta}9-THCA-A induces browning of iWAT and has a potent anti-inflammatory activity

pharmacology and toxicology↗